BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 1803180)

  • 1. Eradication of leukaemic marrow and prevention of leukaemia relapse with total body irradiation and bone marrow transplantation.
    Frassoni F
    Med Oncol Tumor Pharmacother; 1991; 8(3):189-201. PubMed ID: 1803180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed chimerism after allogeneic marrow transplantation for leukaemia: correlation with dose of total body irradiation and graft-versus-host disease.
    Frassoni F; Strada P; Sessarego M; Miceli S; Corvò R; Scarpati D; Vitale V; Piaggio G; Raffo MR; Sogno G
    Bone Marrow Transplant; 1990 Apr; 5(4):235-40. PubMed ID: 2186836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantation.
    Frassoni F; Scarpati D; Bacigalupo A; Vitale V; Corvo R; Miceli S; Gualandi F; Occhini D; Clavio M; van Lint MT
    Br J Haematol; 1989 Oct; 73(2):211-6. PubMed ID: 2684259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation.
    Bacigalupo A; Vitale V; Corvò R; Barra S; Lamparelli T; Gualandi F; Mordini N; Berisso G; Bregante S; Raiola AM; Van Lint MT; Frassoni F
    Br J Haematol; 2000 Jan; 108(1):99-104. PubMed ID: 10651732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow.
    Bär BM; Schattenberg A; De Man AJ; Hoogenhout MJ; Boezeman J; de Witte T
    Bone Marrow Transplant; 1992 Jul; 10(1):45-52. PubMed ID: 1515878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation.
    Alyea E; Neuberg D; Mauch P; Marcus K; Freedman A; Webb I; Anderson K; Schlossman R; Fisher D; Gribben J; Ritz J; Soiffer R
    Biol Blood Marrow Transplant; 2002; 8(3):139-44. PubMed ID: 11939603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant.
    Corvò R; Paoli G; Barra S; Bacigalupo A; Van Lint MT; Franzone P; Frassoni F; Scarpati D; Bacigalupo A; Vitale V
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):497-503. PubMed ID: 10078628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation.
    Truitt RL; Atasoylu AA
    Blood; 1991 Jun; 77(11):2515-23. PubMed ID: 2039833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group.
    Brown RA; Wolff SN; Fay JW; Pineiro L; Collins RH; Lynch JP; Stevens D; Greer J; Herzig RH; Herzig GP
    Leuk Lymphoma; 1996 Jul; 22(3-4):271-7. PubMed ID: 8819076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mixed chimerism and immune modulation on GVHD, disease recurrence and survival after HLA-identical marrow transplantation for hematologic malignancies.
    Park SJ; Min WS; Yang IH; Kim HJ; Min CK; Eom HS; Kim DW; Han CW; Lee JW; Kim CC
    Korean J Intern Med; 2000 Dec; 15(3):224-31. PubMed ID: 11242811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial.
    Bolaños-Meade J; Cooke KR; Gamper CJ; Ali SA; Ambinder RF; Borrello IM; Fuchs EJ; Gladstone DE; Gocke CB; Huff CA; Luznik L; Swinnen LJ; Symons HJ; Terezakis SA; Wagner-Johnston N; Jones RJ; Brodsky RA
    Lancet Haematol; 2019 Apr; 6(4):e183-e193. PubMed ID: 30878319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.
    Soiffer RJ; Fairclough D; Robertson M; Alyea E; Anderson K; Freedman A; Bartlett-Pandite L; Fisher D; Schlossman RL; Stone R; Murray C; Freeman A; Marcus K; Mauch P; Nadler L; Ritz J
    Blood; 1997 Apr; 89(8):3039-47. PubMed ID: 9108425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of allogeneic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemia.
    Locatelli F; Pession A; Comoli P; Bonetti F; Giorgiani G; Zecca M; Taibi RM; Mongini ME; Ambroselli F; de Stefano P; Severi F; Paolucci G
    Br J Haematol; 1996 Jan; 92(1):49-54. PubMed ID: 8562410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.
    Bordigoni P; Esperou H; Souillet G; Pico J; Michel G; Lacour B; Reiffers J; Sadoun A; Rohrlich P; Jouet JP; Milpied N; Lutz P; Plouvier E; Cornu G; Vannier JP; Gandemer V; Rubie H; Gratecos N; Leverger G; Stephan JL; Boutard P; Vernant JP
    Br J Haematol; 1998 Aug; 102(3):656-65. PubMed ID: 9722290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
    Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.
    Mackinnon S; Barnett L; Bourhis JH; Black P; Heller G; O'Reilly RJ
    Blood; 1992 Dec; 80(12):3235-41. PubMed ID: 1467526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
    Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
    J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.